Home › Colon Cancer › Maryland › Baltimore
Pag-aaral pangklinika para sa Colon Cancer sa Baltimore, MD
Isang pag-aaral para sa Colon Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Baltimore. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Family Communications After Genetic Testing
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- Sinai Hospital of Baltimore, Baltimore
- UM Saint Joseph Medical Center, Towson · 8 mi ang layo
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Nagre-recruitPhase 3
- University of Maryland ( Site 2016), Baltimore
- Greater Baltimore Medical Center ( Site 0068), Baltimore
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Nagre-recruitPhase 3
- Greater Baltimore Medical Center, Baltimore
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Nagre-recruitPhase 3
- Saint Agnes Hospital, Baltimore
A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
Nagre-recruitPhase 2
- University of Maryland Greenbaum, Baltimore
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Nagre-recruit
- Kaiser Permanente-Woodlawn Medical Center, Baltimore
- Kaiser Permanente Lutherville - Timonium Medical Center, Lutherville · 9 mi ang layo
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Nagre-recruitPhase 2/3
- Greater Baltimore Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- Saint Agnes Hospital, Baltimore
- at 6 pa
KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer
Nagre-recruitPhase 1
- Sidney Kimmel Comprehensive Cancer Center, Baltimore
EXoPERT EMERALD Clinical Study
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- John Hopkins University, Baltimore
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Nagre-recruitPhase 1
- Advanced Molecular Imaging and Therapy, Glen Burnie · 9 mi ang layo
- United Theranostics - Chesapeake, Glen Burnie · 9 mi ang layo
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Nagre-recruitPhase 1
- Johns Hopkins University, Baltimore
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Nagre-recruitPhase 1/2
- Johns Hopkins University, Baltimore
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Towson · 8 mi ang layo
Pag-aaral para sa Colon Cancer sa ibang lungsod
- Boston, MA22 pag-aaral
- New York City, NY22 pag-aaral
- Houston, TX20 pag-aaral
- Los Angeles, CA16 pag-aaral
- Nashville, TN16 pag-aaral
- St. Louis, MO15 pag-aaral
- Arlington, VA15 pag-aaral
- Chicago, IL14 pag-aaral
- San Antonio, TX14 pag-aaral
- Baldwin Park, CA14 pag-aaral
- Tampa, FL13 pag-aaral
- Washington, DC12 pag-aaral
Iba pang pag-aaral sa Baltimore
- Non-Small Cell Lung Cancer60 pag-aaral
- Kanser sa Suso47 pag-aaral
- Kanser sa Prostate43 pag-aaral
- Kanser sa Baga40 pag-aaral
- Kanser (lahat ng uri)37 pag-aaral
- Kanser sa Pancreas31 pag-aaral
- Colorectal Cancer31 pag-aaral
- Metastatic Cancer28 pag-aaral
- Obesity26 pag-aaral
- Kanser sa Pantog24 pag-aaral
- Pagkabigo ng Puso24 pag-aaral
- Kanser sa Ovary22 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.